Idera Pharmaceuticals, Inc. (IDRA) Posts Narrower than Expected Q1 Loss

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q1 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Greene County Bancorp, Inc. (GCBC) Reports Q3 EPS of $0.34
• General Motors (GM) PT Raised to $45 at Piper Sandler